Table of Contents
Chapter 1. Global Rare Disease Genetic Testing Market Executive Summary
1.1. Global Rare Disease Genetic Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Disease Type
1.3.2. By Technology
1.3.3. By Specialty
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Rare Disease Genetic Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Rare Disease Genetic Testing Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Genetic Testing Technologies
3.1.2. Increased Awareness and Diagnosis of Rare Diseases
3.1.3. Rising Prevalence of Rare Diseases
3.2. Market Challenges
3.2.1. High Costs and Limited Accessibility
3.3. Market Opportunities
3.3.1. Personalized Medicine
3.3.2. Expansion in Emerging Markets
Chapter 4. Global Rare Disease Genetic Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Rare Disease Genetic Testing Market Size & Forecasts by Disease Type 2022-2032
5.1. Segment Dashboard
5.2. Global Rare Disease Genetic Testing Market: Disease Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Neurological Disease
5.2.2. Immunological Disorders
5.2.3. Hematology Diseases
5.2.4. Endocrine & Metabolism Diseases
5.2.5. Cancer
5.2.6. Musculoskeletal Disorders
5.2.7. Cardiovascular Disorders (CVDs)
5.2.8. Dermatology Disease
5.2.9. Others
Chapter 6. Global Rare Disease Genetic Testing Market Size & Forecasts by Technology 2022-2032
6.1. Segment Dashboard
6.2. Global Rare Disease Genetic Testing Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Next-Generation Sequencing (NGS)
6.2.2. Whole Exome Sequencing
6.2.3. Whole Genome Sequencing
6.2.4. Array Technology
6.2.5. PCR-based Testing
6.2.6. FISH
6.2.7. Sanger Sequencing
6.2.8. Karyotyping
Chapter 7. Global Rare Disease Genetic Testing Market Size & Forecasts by Specialty 2022-2032
7.1. Segment Dashboard
7.2. Global Rare Disease Genetic Testing Market: Specialty Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Molecular Genetic Tests
7.2.2. Chromosomal Genetic Tests
7.2.3. Biochemical Genetic Tests
Chapter 8. Global Rare Disease Genetic Testing Market Size & Forecasts by End-Use 2022-2032
8.1. Segment Dashboard
8.2. Global Rare Disease Genetic Testing Market: End-Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
8.2.1. Research Laboratories & CROs
8.2.2. Hospitals & Clinics
8.2.3. Diagnostic Laboratories
Chapter 9. Global Rare Disease Genetic Testing Market Size & Forecasts by Region 2022-2032
9.1. North America Rare Disease Genetic Testing Market
9.1.1. U.S. Rare Disease Genetic Testing Market
9.1.1.1. Disease Type breakdown size & forecasts, 2022-2032
9.1.1.2. Technology breakdown size & forecasts, 2022-2032
9.1.1.3. Specialty breakdown size & forecasts, 2022-2032
9.1.1.4. End-Use breakdown size & forecasts, 2022-2032
9.1.2. Canada Rare Disease Genetic Testing Market
9.2. Europe Rare Disease Genetic Testing Market
9.2.1. U.K. Rare Disease Genetic Testing Market
9.2.2. Germany Rare Disease Genetic Testing Market
9.2.3. France Rare Disease Genetic Testing Market
9.2.4. Spain Rare Disease Genetic Testing Market
9.2.5. Italy Rare Disease Genetic Testing Market
9.2.6. Rest of Europe Rare Disease Genetic Testing Market
9.3. Asia-Pacific Rare Disease Genetic Testing Market
9.3.1. China Rare Disease Genetic Testing Market
9.3.2. India Rare Disease Genetic Testing Market
9.3.3. Japan Rare Disease Genetic Testing Market
9.3.4. Australia Rare Disease Genetic Testing Market
9.3.5. South Korea Rare Disease Genetic Testing Market
9.3.6. Rest of Asia Pacific Rare Disease Genetic Testing Market
9.4. Latin America Rare Disease Genetic Testing Market
9.4.1. Brazil Rare Disease Genetic Testing Market
9.4.2. Mexico Rare Disease Genetic Testing Market
9.4.3. Rest of Latin America Rare Disease Genetic Testing Market
9.5. Middle East & Africa Rare Disease Genetic Testing Market
9.5.1. Saudi Arabia Rare Disease Genetic Testing Market
9.5.2. South Africa Rare Disease Genetic Testing Market
9.5.3. Rest of Middle East & Africa Rare Disease Genetic Testing Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Quest Diagnostics Inc.
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Centogene N.V.
10.3.3. Invitae Corp.
10.3.4. 3billion, Inc.
10.3.5. Arup Laboratories
10.3.6. Eurofins Scientific
10.3.7. Strand Life Sciences
10.3.8. Ambry Genetics
10.3.9. Perkin Elmer, Inc.
10.3.10. Realm IDX, Inc.
10.3.11. Macrogen, Inc.
10.3.12. Baylor Genetics
10.3.13. Color Genomics, Inc.
10.3.14. Health Network Laboratories
10.3.15. PreventionGenetics
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes